Nerve treatment methods

Access full-text files

Date

2018-11-27

Authors

George D. Bittner

Journal Title

Journal ISSN

Volume Title

Publisher

United States Patent and Trademark Office

Abstract

The present disclosure is directed to the use of fusogenic compounds such as polyethylene glycol (PEG) in combination with antioxidants, calcium-containing and calcium-free solutions for treating damaged nerves, such as for reconnecting severed nerves.

Description

Keywords

LCSH Subject Headings

Citation